| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1,004,242 | 74% | $20.11 | +$20,199,404 |
| Sells | 7 | -350,178 | 26% | $21.38 | -$7,485,319 |
| Net | -4 | +654,064 | 48% | +$12,714,085 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Novo Holdings A/S | 10%+ Owner | $95,781,722 | 14 Sep 2022 | ||
| Peter A. Thompson | Director, 10%+ Owner | $8,933,533 | +$10,000,000 | 16 Jun 2025 | |
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | $8,933,533 | +$10,000,000 | 03 Apr 2025 | |
| KEVIN KOCH | President and CEO, Director | $6,183,518 | -$177,122 | -2.8% | 12 Aug 2025 |
| R. Michael Carruthers | Chief Financial Officer | $1,591,209 | -$40,745 | -2.5% | 12 Aug 2025 |
| Alan J. Russell | Chief Scientific Officer, Director | $931,607 | -$3,623,270 | -80% | 12 Nov 2025 |
| Robert Blaustein | Chief Development Officer | $821,241 | 12 Aug 2025 | ||
| Joanne M. Donovan | Cmo | $776,938 | -$123,677 | -14% | 12 Aug 2025 |
| Behrad Derakhshan | Chief Business Officer | $753,957 | -$61,185 | -7.5% | 12 Aug 2025 |
| Marc Semigran | Chief Development Officer | $639,313 | 24 Dec 2024 | ||
| Badreddin Edris | Director | $583,500 | -$3,399,466 | -85% | 21 Jan 2026 |
| John R. Moore | General Counsel | $574,083 | -$59,854 | -9.4% | 12 Aug 2025 |
| Jonathan C. Fox | Director | $569,563 | +$199,403 | +54% | 02 Jan 2026 |
| Christopher Nathan Martin | Director | 19 Nov 2025 | |||
| Arlene Morris | Director | 16 Jun 2025 | |||
| Laura Brege | Director | 16 Jun 2025 | |||
| JONATHAN D. ROOT | Director | 16 Jun 2025 | |||
| Michael Nofi | Chief Financial Officer | 10 Nov 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|